Should You Buy Reborn Coffee, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Reborn Coffee, Inc. (REBN) presents a moderate quality profile with a QOC score of 4.9/10. Trading at $0.79, separating genuine undervalued opportunities from value traps is essential, as detailed by our model data.
The short answer: 1 of 1 CirclFi valuation models project upside for Reborn Coffee, Inc. (REBN) at $0.79 — the model consensus leans bullish, with a Quality Score of 4.9/10 and Value-Trap risk of 33/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Reborn Coffee, Inc. (REBN) in 2026?
What Is the Bull Case vs the Bear Case for Reborn Coffee, Inc. (REBN)?
| Bull case — $1.12 target (+43.1%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +43.1% across 1 bullish models from the current price of $0.79. | No active model flags significant downside for REBN. The Value Trap score of 33/100 still argues for some caution. |
| According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $1.12 (+43.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: private label penetration could provide meaningful support for Reborn Coffee, Inc.'s revenue and margin trajectory in the Restaurants space. |
How Does REBN Compare to Its Restaurants Peers?
Valuation data pages: HWH · KITL · VENU · JMKE · NDLS · CCHH · ARCO · LOCO · BH · EAT · CMG
Which Other Stocks Score Like REBN on Quality?
Closest companies to REBN’s Quality of Company score of 4.9/10, across all industries.
- GRML — Greenland Mines Ltd (QOC 4.9) · analysis
- PVCT — Provectus Biopharmaceuticals, Inc. (QOC 4.9) · analysis
- BGY — BlackRock Enhanced International Dividend Trust (QOC 4.9) · analysis
- CMPX — Compass Therapeutics, Inc. (QOC 4.9) · analysis
- NGNE — Neurogene Inc. (QOC 4.9) · analysis
- GRO — Brazil Potash Corp. (QOC 4.9) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Restaurants Screens Does REBN Appear In?
So Is Reborn Coffee, Inc. (REBN) Worth Buying in 2026?
Reborn Coffee, Inc. at $0.79 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 4.9/10, and the median fair value of $1.12 implies +43.1% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Reborn Coffee, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About REBN Stock?
Should I buy REBN stock right now?
Based on CirclFi's multi-model analysis, 1 of 1 models see upside for REBN at $0.79. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 4.9/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Reborn Coffee, Inc.?
Key risks include: a below-average Quality Score of 4.9/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Restaurants companies. Always diversify and consult a financial advisor.
How does REBN compare to its competitors?
Among Restaurants peers, REBN holds a Quality Score of 4.9/10. Comparable companies include HWH (QOC 4.9), KITL (QOC 4.1), VENU (QOC 5.1). The relative ranking helps investors identify whether REBN offers better fundamental quality than alternatives in the same sector.
Is REBN a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. REBN's Quality Score of 4.9/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy REBN at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $1.12 to $1.12. At $0.79, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for REBN.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →